Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults15 Oct 2026

Popular Vehicles and Services Ltd

In accordance with SEBI LODR Regulations, 2015 and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information in terms of Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has provided a business update for the quarter and half year ended 30th September, 2026.

Popular Vehicles and Services Ltd reported a strong, broad-based YoY growth in new vehicle volumes in Q2FY27 and H1FY27, driven by healthy organic growth across the existing network and contributions from recent acquisitions. The company also witnessed encouraging customer demand and strong sales momentum during the festive season, with demand expected to remain positive through the upcoming festive period.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults15 Oct 2026

HCL Technologies Ltd

Enclosed please find an earnings call transcript.

HCL Technologies Ltd. announced its Q2 FY27 earnings, with a solid quarter driven by Advanced AI services, new bookings, and margin expansion. The company reported a 2.3% sequential revenue growth and a 2.6% YoY growth, with Advanced AI revenue reaching $219 million, up 28.4% sequentially and 78% YoY. The EBIT margin improved to 18.2%, an increase of 131 basis points sequentially and 71 basis points YoY.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults15 Oct 2026

Kabra Extrusion Technik Limited

Press Release

Kabra Extrusion Technik Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a significant increase in revenue, EBITDA, and PAT.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults15 Oct 2026

Kabra Extrusiontechnik Ltd

Press Release

Kabra Extrusiontechnik Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a significant increase in revenue, EBITDA, and PAT. The company's Geon division has led the growth, with revenues up 2.5 times year-on-year and contributing 75% of consolidated revenues in Q2 FY27.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveFundraise15 Oct 2026

Prestige Estates Projects Limited

General Updates

Prestige Estates Projects Limited has informed the Exchange about the consummation of the first tranche of the transaction in its Hospitality Portfolio through a strategic partnership with CPP Investment Board Private Holdings (4) Inc. and Prestige Hospitality Ventures Limited. The transaction involves the acquisition of 10% and 5.79% of PHVL's shareholding by CPPIB for a total consideration of INR 1,500,00,00,000.

Read more →📎 1 attachment
BSECompany Update▲ PositiveFundraise15 Oct 2026

Prestige Estates Projects Ltd

In continuation with earlier announcements dated August 10, 2026, and September 29, 2026, the Company has consummated the first tranche of transaction in Hospitality Portfolio through strategic partnership with CPP Investments.

Prestige Estates Projects Ltd has consummated the first tranche of its transaction in the Hospitality Portfolio through a strategic partnership with CPP Investments, acquiring 10% and 5.79% of PHVL's shareholding for INR 950,00,00,000 and INR 550,00,00,000 respectively.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults15 Oct 2026

Mangalam Worldwide Limited

Press Release

Mangalam Worldwide Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 31% YoY increase in PAT to ₹13.82 crores and a 13.4% YoY growth in total income to ₹361 crores. The company has also incorporated a wholly owned subsidiary in Belgium to expand its international presence.

Read more →📎 1 attachment
BSEResult▲ PositiveResults15 Oct 2026

SBC Exports Ltd

Result for the Quarter and Half Year Ended on 30th September 2026

SBC Exports Ltd has announced its results for the quarter and half year ended on 30th September 2026, with a net profit of ₹1080.14 crore and a total comprehensive income of ₹1086.53 crore. The company's revenue from operations was ₹13,831.19 crore, and its expenses were ₹12,866.61 crore. The earnings per share from continuing operations was ₹0.23.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A15 Oct 2026

Mankind Pharma Limited

Press Release

Mankind Pharma Limited has announced that its Board of Directors has approved the acquisition of a majority stake (70%) in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company, through its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. The acquisition is part of the Company's long-term strategy to build a global innovation-led pharmaceutical business.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults15 Oct 2026

L&T Finance Limited

Press Release

L&T Finance Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a consolidated Profit After Tax (PAT) of Rs. 975 Crore, up 33% YoY, and a consolidated book of Rs. 1,36,635 Crore, up 28% YoY.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A15 Oct 2026

Mankind Pharma Ltd

Please find attached press release titled "Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-Generation CAR-T Therapies".

Mankind Pharma Ltd has announced that its Board of Directors has approved the acquisition of a majority stake (70%) in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company, through its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. The acquisition is part of the company's long-term strategy to build a global innovation-led pharmaceutical business.

Read more →📎 1 attachment
NSEAcquisition▲ PositiveM&A15 Oct 2026

Mankind Pharma Limited

Acquisition

Mankind Pharma Limited has informed the Exchange about Acquisition of majority stake (70%) in Armed Cell Therapeutics B.V. (ACTx) through its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. for EUR 48Mn in installments.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveM&A15 Oct 2026

Mankind Pharma Limited

Outcome of Board Meeting

Mankind Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on October 15, 2026. The Board of Directors has considered and approved an additional investment of up to EUR 45Mn in Mankind Pharma (Netherlands) B.V. and the acquisition of a majority stake (i.e., 70%) in Armed Cell Therapeutics B.V. through Mankind Netherlands.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults15 Oct 2026

Sri Lotus Developers and Realty Limited

Press Release

Sri Lotus Developers and Realty Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with strong Q2 FY27 momentum, including 83% YoY growth in pre-sales to INR 470 Crs, 53% YoY growth in total revenue to INR 269 Crs, and 113% YoY growth in EBITDA to INR 107 Crs.

Read more →📎 1 attachment
← PreviousPage 281 of 939Next →